Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Bod unveils its latest launch of cannabis treatment
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Bod unveils its latest launch of cannabis treatment
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Bod unveils its latest launch of cannabis treatment
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Bod unveils its latest launch of cannabis treatment
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Bod unveils its latest launch of cannabis treatment
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Centrepoint acquires leading Xplan customisation business
    • News

    Centrepoint acquires leading Xplan customisation business

    As part of their corporate refresh strategy, financial services support company Centrepoint Alliance (ASX: CAF) has significantly increased its service offering to clients via the acquisition of Enzumo, its clients and recurring revenue.  The acquisition of Enzumo for $1.5m from Chant West Holdings (ASX: CWL) will accelerate Centrepoint’s new financial model whilst enhancing their technology

    Read More
    Public
  • High Australian debt sees Credit Intelligence expand with strategic acquisition
    • News

    High Australian debt sees Credit Intelligence expand with strategic acquisition

    With financial hardships brought upon as a result of COVID-19, debt management company Credit Intelligence (ASX: CI1) is set to expand their exposure to Australia’s high levels of personal debt via the 60% acquisition of debt negotiation business Chapter Two Holdings (CTH).  Listing on the ASX in 2018 but primarily operating in Hong Kong’s credit

    Read More
    Public
  • Acrux shares surge 37% on appointment of U.S pharmaceuticals distributor
    • News

    Acrux shares surge 37% on appointment of U.S pharmaceuticals distributor

    Pharmaceuticals developer Acrux (ASX: ACR) is set to expedite commercialisation of its generic topical products in the United States via the appointment of TruPharma as their exclusive sales, marketing and distribution partner in America.  The agreement will see TruPharma take over responsibility for getting Acrux products approved by the U.S Food and Drug Administration (FDA)

    Read More
    Public
  • Veris continues winning streak, lands blue chip and defence contracts
    • News

    Veris continues winning streak, lands blue chip and defence contracts

    Surveying and communications company Veris (ASX: VRS) continues to defy its small market capitalisation by adding to its recent slew of contract wins, today announcing extensions awarded from BHP Billiton (ASX: BHP) and OZ Minerals (ASX: OZL) as well as a new defence company – Cubic Defence.  The total value of the contracts is $4.3

    Read More
    Public
  • Landmark court ruling opens up ASX conglomerates to employee class action
    • News

    Landmark court ruling opens up ASX conglomerates to employee class action

    Last week the Federal Court handed down a judgment which held that casual employees can be entitled to the same benefits permanent employees hold, such as paid personal leave and paid annual leave.  Previously, the common understanding was that casual employees are not entitled to as many benefits under the National Employment Standards (NES) which

    Read More
    Public
  • Jaxsta accelerating growth, sacrifices revenue for mass user acquisition
    • News

    Jaxsta accelerating growth, sacrifices revenue for mass user acquisition

    Since making their music networking and data platform free in response to the music industry’s challenges brought upon by COVID-19, Jaxsta (ASX: JXT) has had more than 10,000 users sign up for Jaxsta Pro in the past month.  As an initiative supported by leading industry labels, Jaxsta has been able to significantly increase its reach

    Read More
    Public
  • Testing confirms infection resistance, First Graphene signs face mask supply deal
    • News

    Testing confirms infection resistance, First Graphene signs face mask supply deal

    As world populations seek increased protection from airborne infections, advanced materials company First Graphene (ASX: FGR) has completed initial testing of their graphene as coating into protective equipment with excellent results.  The testing was done in collaboration with planarTECH and their personal protective equipment (PPE) which confirmed anti-static and bacteria-resistant properties. With these results, planarTECH

    Read More
    Public
  • City of Melville awards SECOS with $600k supply contract for compost bags
    • News

    City of Melville awards SECOS with $600k supply contract for compost bags

    Envirotech developer and retailer SECOS Group (ASX: SES) continues to see support from City Councils for their compostable bags designed to divert organic waste from landfills with the City of Melville the latest to engage SECOS products.  The contract valued at more than $600,000 annually, and with options to renew over the next 3 years,

    Read More
    Public
  • Raiz launches Bitcoin portfolio for loose change to be invested
    • News

    Raiz launches Bitcoin portfolio for loose change to be invested

    Fintech micro-investment firm Raiz Invest (ASX: RZI) is set to launch a new investment portfolio for customers and users of the Raiz app to invest loose change in Bitcoin, offering investors with exposure to cryptocurrency.  The new portfolio, to be named Sapphire, has been specifically developed to meet demand from clientele who have continually expressed

    Read More
    Public
  • Majority of Target stores to be converted to Kmart or closed
    • News

    Majority of Target stores to be converted to Kmart or closed

    Wesfarmers (ASX: WES) has completed the first phase review of its iconic Target brand, confirming that its financial viability is not sustainable and that the majority of stores will be transformed into Kmart stores which better reflects the retail needs of Australian customers.  The decision comes as Target has continued to see declining sales with

    Read More
    Public
  • «
  • ‹
  • 290
  • 291
  • 292
  • 293
  • 294
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.